Revive BioScience Ltd. Rescinds Asset Purchase Deal with Axxess Pharma Inc.
24 Junho 2014 - 7:48PM
Revive BioScience Ltd. has rescinded the asset purchase agreement
for the company's TapOut brand of products and related patents with
Axxess Pharma Inc. for (OTC Pink:AXXE) for failure to complete the
transaction. As part of the rescission Revive is demanding that all
its assets to be returned to Revive by Axxess. Revive will further
be looking to recover damages from Axxess based on the many
misrepresentations Axxess has made in the market place about its
assets when the asset purchase was never properly completed.
A spokesman for Revive stated, "The company has made every
effort to complete the transaction which was falsely stated in a
press release by Axxess Pharma to have been concluded. We need to
assure the market that Revive has acted fairly in trying to
complete the transaction, but has not been able to deal with Axxess
management on many of the points needed to be addressed. It is
therefore necessary to rescind the deal and pursue all legal
remedies open to Revive against Axxess."
Forward Looking Statement:
This news release contains "forward-looking statements" as that
term is defined in Section 27A of the United States Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Statements in this press release which are not purely historical
are forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the future.
Such forward-looking statements include, among other things, the
development, costs and results of our financial networking and
press release businesses. Actual results could differ from those
projected in any forward-looking statements due to numerous
factors. Such factors include, among others, the inherent
uncertainties associated with a smaller public company engaged in
an industry subject to rapid change. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements, or
to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that the beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
such beliefs, plans, expectations or intentions will prove to be
accurate.
CONTACT: 647-799-1051
Allstar Health Brands (PK) (USOTC:ALST)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Allstar Health Brands (PK) (USOTC:ALST)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Allstar Health Brands Inc (PK) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de